Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XOMAP | US
-0.03
-0.13%
Healthcare
Biotechnology
30/06/2024
12/03/2026
25.75
25.75
25.75
25.75
XOMA Corporation operates as a biotech royalty aggregator in Europe the United States and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville California.
View LessLow 6-Month Volatility (<30%)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
4.0%1 month
6.0%3 months
12.3%6 months
12.6%26.27
-
-
1.22
0.50
-
-
-
-19.10M
-
-
8.20
-9.73
37.00
568.60
-17.35
3.48
0.01
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.14
Range1M
0.52
Range3M
1.36
Rel. volume
0.40
Price X volume
11.46K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.4 | 0 | 0.12% | 25.57 | 121.93% |
| SABSW | SABSW | Biotechnology | 0.0366 | 0 | -12.02% | 0.17 | 11.58% |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 1.6 | 0 | -6.98% | n/a | 5.40% |
| Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.0199 | 0 | -0.50% | n/a | 0.00% |
| JSPRW | JSPRW | Biotechnology | 0.0227 | 0 | 11.27% | n/a | 2.31% |
| ICUCW | ICUCW | Biotechnology | 0.0251 | 0 | -15.49% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.0907 | 0 | -22.87% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 35.125 | 0 | -0.48% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | 26.27 | 41.03 | Cheaper |
| Price to Book | - | 15.55 | - |
| Dividend Yield | 8.20 | 2.20 | Leader |
| Std. Deviation (3M) | 12.25 | 72.80 | Lower Risk |
| Debt to Equity | 1.22 | -1.23 | Expensive |
| Debt to Assets | 0.50 | 0.25 | Expensive |
| Market Cap | - | 3.66B | - |